Whether enhanced complement activation in ADAMTS-13 deficient environment23 or other factors such as HMGB-132 are the underlying mechanisms for the poorer outcome of Adamts13−/− mice in our IPA model, is currently not clear and needs further investigations. This evidence concerns the gene ADAMTS13 and Ito hypomelanosis.